Irina Gershgorin is currently leading Analytics and Statistics within Global MSAT at Legend Biotech, where she supports commercial manufacturing. She holds an Hon. B.Sc. from the University of Toronto and a PhD in computational biology from the Courant Institute at NYU. Prior to joining Legend, Irina spent nearly eight years at Novartis Cell and Gene Therapies, supporting KYMRIAH, the first ever cell therapy to be approved, as well as other pipeline programs. In addition to regular CMC support, Irina’s work has focused on correlational analyses. She has applied statistical and machine learning methods to investigate relationships between product attributes, manufacturability and clinical outcomes, with findings presented at ASH, ASCGT, AACR, and IABS.